Caricamento...
Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy
BACKGROUND: Natalizumab is a monoclonal antibody approved for the treatment of patients with relapsing-remitting multiple sclerosis. According to the current clinical recommendations, its use during pregnancy should be carefully evaluated only in women with highly active disease who plan a pregnancy...
Salvato in:
| Pubblicato in: | Ital J Pediatr |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7987111/ https://ncbi.nlm.nih.gov/pubmed/33757559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-021-01025-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|